Literature DB >> 6290053

Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.

N Niederle, W Krischke, K Bremer, C G Schmidt, S Seeber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6290053     DOI： 10.1016/s0305-7372(82)80087-x

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

1.  First-line chemotherapy rechallenge after relapse in small cell lung cancer.

Authors:  M Vincent; B Evans; I Smith
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.

Authors:  C Collins; C S Higano; R B Livingston; B R Griffin; M D Keppen; T P Miller
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.

Authors:  N Niederle; J Schütte; W Krischke; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.